⭐ BESTSELLER 🏥 NABL ACCREDITED

Flow For Lymphoma/ CLPD / Lymphoma MRD

Flow For Lymphoma/CLPD/Lymphoma MRD assesses minimal residual disease (MRD) in lymphoma patients using flow cytometry, a technique to detect remaining cancerous cells after treatment.

24 hrs

Report Ready

No Fasting

Fasting

5-99

Age Group

Home

Collection

Preparation

Why this test

Fasting Required

Not Required

⏱ Report Time

24 hrs

🧫 Sample Type

Blood

🎂 Age Group

5-99

👤 Gender

Male,Female

🏠 Collection

Home Visit

Flow for Lymphoma/ CLPD / lymphoma MRD

₹43,500

Inclusive of all taxes. Free home collection.

Add to Cart

View Smart Lab Report Sample

NABL
Accredited

4.9
Google

Secure
Payment

Free
Cancel

Related Packages

Your Health Checkup Journey in 4 Steps

Step 01

Choose & Book Your Test

Search by symptom, organ, or test name. Pick a slot from 6am. Done in under 3 minutes.

⏱ Under 3 Minutes

Step 02

Instant Confirmation

Get immediate booking confirmation on WhatsApp — with your slot details, phlebotomist name, and prep instructions.

Step 03

Hassle-Free Home Collection

Your verified phlebotomist arrives at your door within 60 minutes — with a cold-chain kit, gloves, and one-prick collection.

Step 04

Reports + Nutrition Insights

Your report is ready in 6–12 hours — with flagged values explained in plain language and personalised nutrition guidance.

Book In Under 3 Minutes, From Anywhere

Search by symptom ("I feel tired"), organ (Thyroid, Liver), or test name (CBC, HbA1c). Upload a prescription photo and we'll auto-match your tests. Guest OTP checkout — no account needed.

⏱

3 minutes to complete booking

Book Now

Choose

Instant

Hassle-Free

Reports

Miduty’s Smart Report

Now understanding lab reports got easier. Miduty is one of the most trusted brands in the Indian healthcare market, with years of experience helping people improve their health naturally through data-driven wellness and expert guidance. With a 75% repeat customer rate, we’re proud to be a brand people trust with their long-term wellbeing.